Search Count: 24
 |
Cryo-Em Structure Of Neutralizing Murine Antibody Ws.Hsv-1.24 In Complex With Hsv-1 Glycoprotein B Trimer Gb-Ecto.516P.531E
Organism: Human alphaherpesvirus 1, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2025-09-10 Classification: VIRAL PROTEIN Ligands: NAG |
Organism: Human alphaherpesvirus 1, Mus musculus
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-10
Ligands: NAG
 |
Cryo-Em Structure Of Neutralizing Human Antibody D48 In Complex With Hsv-1 Glycoprotein B Trimer Gb-Ecto.516P.531E.Ds
Organism: Human alphaherpesvirus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-09-10 Classification: VIRAL PROTEIN Ligands: NAG |
Organism: Human alphaherpesvirus 1, Homo sapiens
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-10
Ligands: NAG
 |
Cryo-Em Structure Of Neutralizing Human Antibody D48 In Complex With Hsv-1 Glycoprotein B Trimer Gb-Ecto.516P
Organism: Human alphaherpesvirus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-09-10 Classification: VIRAL PROTEIN Ligands: NAG |
Organism: Human alphaherpesvirus 1, Homo sapiens
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-10
Ligands: NAG
 |
Cryo-Em Structure Of Neutralizing Human Antibody D48 In Complex With Hsv-1 Glycoprotein B Trimer Gb-Ecto.516P.531E
Organism: Human alphaherpesvirus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-09-10 Classification: VIRAL PROTEIN Ligands: NAG |
Organism: Human alphaherpesvirus 1, Homo sapiens
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-10
Ligands: NAG
 |
Cryo-Em Structure Of Gb-Ecto.516P.531E.Ds, A Prefusion-Stabilized Hsv-1 Glycoprotein B Extracellular Domain
Organism: Human alphaherpesvirus 1
Method: ELECTRON MICROSCOPY Release Date: 2025-09-10 Classification: VIRAL PROTEIN Ligands: NAG |
Organism: Human alphaherpesvirus 1
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-10
Ligands: NAG
 |
Cryo-Em Structure Of Gb-Ecto.516P.531E, A Prefusion-Stabilized Hsv-1 Glycoprotein B Extracellular Domain
Organism: Human alphaherpesvirus 1
Method: ELECTRON MICROSCOPY Release Date: 2025-09-10 Classification: VIRAL PROTEIN Ligands: NAG |
Organism: Human alphaherpesvirus 1
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-10
Ligands: NAG
 |
Cryo-Em Structure Of Gb-Ecto.516P, An Hsv-1 Glycoprotein B Extracellular Domain
Organism: Human alphaherpesvirus 1
Method: ELECTRON MICROSCOPY Release Date: 2025-09-10 Classification: VIRAL PROTEIN Ligands: NAG |
Organism: Human alphaherpesvirus 1
Method: ELECTRON MICROSCOPY
Release Date: 2025-09-10
Ligands: NAG
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) E166V Mutant In Complex With Inhibitor Enstrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 7YY, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 7YY, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F And E166V) In Complex With Inhibitor Enstrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 7YY, VIB, GOL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 7YY, VIB, GOL
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Double Mutant (T21I And E166V) In Complex With Inhibitor Enstrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 7YY |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 7YY
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) F140L Mutant In Complex With Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 4WI
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Double Mutant (T21I And E166V) In Complex With Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.18 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 4WI
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) A193P Mutant In Complex With Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 4WI
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) L167F Mutant In Complex With Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 4WI
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F And E166V) In Complex With Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 4WI
 |
The Crystal Structure Of Sars-Cov-2 3C-Like Protease Double Mutant (L50F And E166V) In Complex With A Traditional Chinese Medicine Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: ODN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: ODN
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Mutant (T21I) In Complex With Protease Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI, LQZ |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 4WI, LQZ
 |
Sars-Cov-2 Mpro Double Mutant (H41A And T21I) In Complex With Nsp4/5 Peptidyl Substrate
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Mutant (S144A) In Complex With Protease Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 4WI
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Mutant (E166V) In Complex With Protease Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-10-11
Ligands: 4WI